InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure…
John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices and stocks. He also speaks ‘special situation’ companies. ‘(There’s) a change…
Here’s a quick recap of the crypto landscape for Friday (November 7) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with…